Pine Haven Investment Counsel’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
LMFP
ATO
HCM
AAMU
FWCM
Pine Haven Investment Counsel's ABBV Position: Q2 2026 in Review
Pine Haven Investment Counsel increased its AbbVie (ABBV) stake by 0.12% in Q2 2026, buying an estimated $4.52K and bringing the position to 17,973 shares worth $4.52M. The position accounts for 3.04% of the portfolio, ranked #6.
Pine Haven Investment Counsel first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Pine Haven Investment Counsel held 17,973 shares of AbbVie worth $4.52M as of Q2 2026.
- Pine Haven Investment Counsel bought 21 AbbVie shares in Q2 2026, an estimated $4.52K.
- AbbVie made up 3.04% of Pine Haven Investment Counsel's portfolio in Q2 2026, its #6 holding.
- Pine Haven Investment Counsel first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Pine Haven Investment Counsel's 13F filing for Q2 2026, filed 8 Jul 2026.